ArticleBMC plant biology2025
Transcriptome and metabolome reveal the accumulation of secondary metabolites in different species of Dioscorea.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Agro-Industrial Potential of Yam (Foods (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe genus Dioscorea is traditional Chinese medicine producing a variety of pharmacological active substances especially saponins. In our study, the secondary metabolism of Dioscorea zingiberensis and D. opposita that have significantly different saponin contents were investigated.
resultThe saponin content was significantly different between two species. KEGG pathway enrichment analysis of transcriptomic data revealed significant differences between the two species in several metabolic pathways, including secondary metabolite biosynthesis, phenylpropanoid biosynthesis, starch and sucrose metabolism, photosynthesis, flavonoid biosynthesis, and steroid biosynthesis. Notably, 28 differentially expressed genes (DEGs) were linked to steroid biosynthesis. Through further metabolome analysis, we detected a total of 1 010 metabolites, and 212 (52 upregulated and 160 downregulated) differential metabolites (DAMs) were screened. The DAMs were mainly enriched in biosynthesis of secondary metabolites (32), amino acids (17), carbon metabolism (10), pentose phosphate (7), phenylalanine metabolism (6), and steroid (2). The combined analysis of transcriptome and metabolome found that terpenoid backbone biosynthesis, flavonoid biosynthesis and steroid biosynthesis were significantly enriched. In addition, we screened three candidate glycosyltransferase genes involved in dioscin biosynthesis.
conclusionsThe integration of transcriptome and metabolome analyses revealed a strong correlation between metabolite contents and gene expression. Three genes, J5N97_024139 (sterol 3-beta-glucosyltransferase 1, UGT80A2), J5N97_022450 (sterol 3-beta-glucosyltransferase 2, UGT80B1) and J5N97_004795 (UDP-rhamnose transporter 1, URT1), were significantly positively correlated with dioscin biosynthesis. These results provide valuable data for the study of secondary metabolites, particularly saponins, and lay a solid foundation for breeding ideal Dioscorea plants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.